Lifeline Biotechnologies Inc LLBO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.25
- Market Cap
- $941,664.29
- Volume/Avg
- 175,000 / 292,847
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lifeline Biotechnologies Inc is an US-based company engaged in the business of developing and marketing technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. It has developed, tested, and patented a process that assists in the identification of dense breast tissue. The process is to be targeted as a screening protocol assisting in the early detection of breast tissue abnormalities and breast cancers.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- http://www.lbti.co
Valuation
|
Metric
|
LLBO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LLBO
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
LLBO
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Hwgjmxhj | Zgrlrk | $183.1 Bil | |||
| Stryker Corp
SYK
| Wzqyznbxs | Rmq | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Zqbwtbfbn | Qkpkn | $110.1 Bil | |||
| Medtronic PLC
MDT
| Vthtjgp | Fgtcmc | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Pxhtjtzwjl | Lmhrrt | $37.6 Bil | |||
| DexCom Inc
DXCM
| Vpnlzdrs | Vflx | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Brxpgvmf | Wglhld | $24.1 Bil | |||
| Steris PLC
STE
| Xjgpvvt | Bbbvxr | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Lpcwmrmzs | Fhclj | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Gllhsgvk | Bctyr | $16.6 Bil |